|

Ultrasound More Accurate for Malignant Pleural Mesothelioma

Ultrasound More Accurate for Malignant Pleural Mesothelioma

Ultrasound may be a more accurate and cheaper option than CT scans for malignant pleural mesothelioma.

A group of Italian researchers examined the use of ultrasound to help diagnose malignant pleural mesothelioma. The goal was to help doctors locate optimal sites for biopsies.

Diagnosing Malignant Pleural Mesothelioma

Mesothelioma is a rare form of cancer that develops from mesothelium cells. The mesothelium is the lining that covers many of our internal organs. Mesothelioma is caused by exposure to asbestos, a toxic substance used in industrial and consumer products.

When mesothelioma develops in the lining of our lungs, it is called malignant pleural mesothelioma. It can take around 40 years for malignant pleural mesothelioma to develop after asbestos exposure.

Diagnosing malignant pleural mesothelioma can be hard for doctors. It usually requires an initial imaging scan that is confirmed with a tissue biopsy.

A good imaging scan is crucial to an effective biopsy. The biopsy procedure can be difficult on the patient’s body. It’s important for doctors to know the best place to perform the biopsy to get the best tissue sample.

Usually, doctors will perform a computed tomography scan, or CT scan. While effective, this type of scan can have side effects caused by radiation. It is also expensive.

The researchers in this study wanted to find out if a less-risky ultrasound scan would be helpful in locating safe biopsy sites.

Ultrasound May Be More Accurate than CT Scan

The study included 51 patients with malignant pleural mesothelioma. These patients had “pleural thickening” in their lungs. This is when the lining of the lungs becomes damaged by scar tissue from the cancer. The scar tissue made it difficult to locate a safe biopsy site.

Each patient was examined with an ultrasound scan. The researchers found that the ultrasound scan was useful for locating the best biopsy site with 94% accuracy. There were no complications and no need for drainage tubes. Patients were able to be sent home on the second postoperative day.

Ultrasound scans can be a useful and safe alternative to CT scans for diagnosing malignant pleural mesothelioma. This can make it easier for doctors to make a quick diagnosis and start life-saving treatment earlier in the disease progression.

Source

Messina G, Bove M, Natale G, et al. Diagnosis of malignant pleural disease: Ultrasound as “a detective probe” [published online ahead of print, 2022 Nov 22]. Thorac Cancer. 2022;10.1111/1759-7714.14735. doi:10.1111/1759-7714.14735

Similar Posts

  • |

    Mesothelioma Blood Test May Be Possible

    An international team of researchers is studying the proteins found on the surface of cancer cells in an effort to improve mesothelioma diagnosis. The team, made up of scientists from the US, Switzerland, Italy and Chile, has just published their findings on a new kind of test to identify protein-derived mesothelioma biomarkers in blood serum. Mesothelioma is an aggressive cancer of the membranes around organs. Because the most common mesothelioma biomarker, mesothelin, is also overproduced by other kinds of cancer cells, it has only limited diagnostic value. A test to identify a set of proteins produced specifically by mesothelioma cells could greatly improve diagnostic accuracy. Led by Ferdinando Cerciello and Bernd Wollscheid of the Institute of Molecular Systems Biology in…

  • | |

    Needle Biopsy “Simple, Safe & Accurate” for Mesothelioma

    Mesothelioma researchers in China say a biopsy method that involves a single skin puncture can produce good diagnostic results for mesothelioma patients with little pain or risk. The study focused on percutaneous (through the skin) biopsy in patients who had unexplained fluid buildup or swelling in their abdomens. Abdominal distension and fluid buildup (called ascites) can be signs of peritoneal mesothelioma, a rare but aggressive cancer of the abdominal lining caused by exposure to asbestos. Peritoneal mesothelioma accounts for less than 30% of all mesothelioma cases. Because the symptoms may be vague and often develop many decades after asbestos exposure, peritoneal mesothelioma can be especially challenging to diagnose.  Misdiagnosis and under-diagnosis are not uncommon. In the newest study on percutaneous…

  • | |

    Inflammation Both “Friend and Foe” in Mesothelioma

    An immune system response that causes mesothelioma symptoms such as fever, fatigue, and weight loss may also be helpful to clinicians as a way to find and treat the disease. Scientists with The Asbestos Diseases Research Institute in Sydney, Australia make that case that both systemic inflammation (throughout the body) and at the site of a tumor – has long been associated with mesothelioma and other cancers. Inflammation results when the body attempts to address the imbalances of cancer by producing more of certain immune system cells. Some inflammatory markers, such as CD+8 T-cells and C-reactive protein, have been linked to better prognosis in mesothelioma. Other inflammatory markers, such as certain macrophages and a high neutrophil-to-lymphocyte ratio, can signal the…

  • | |

    FDG PET-CT Results Could Lead to Improved Mesothelioma Treatment

    In a recent study, researchers say a better understanding of certain diagnostic criteria could result in more targeted treatments for malignant mesothelioma. In a recent published report, doctors from the medical school at Dicle University in Diyarbakir, Turkey measured the relationship between PET-CT scan results and survival in 177 patients with malignant pleural mesothelioma. The patients were diagnosed between April 2007 and April 2011. They had a mean age of 55.4 and most (56%) were male. Patients in the study all had FDG PET-CT scans before beginning their mesothelioma treatment. FDG PET-CT scanning is a powerful imaging tool for mesothelioma and other cancers that combines a radioactive tracer with a combination of positron emission tomography and computed tomography scanning.  Because…

  • | |

    Mesothelioma Surgeons Report New Biopsy Technique

    A team of surgeons in Maryland have demonstrated how using a standard biopsy tool in a new way could improve the biopsy process for certain mesothelioma patients. An aggressive cancer of the pleural lining around the lungs, malignant pleural mesothelioma usually requires a tissue biopsy to make a definitive diagnosis. Often this is done using a rigid tool called a thoracoscope inserted into the chest wall while the patient is under general anesthesia. However, mesothelioma doctors at Walter Reed National Military Medical Center detail the case of a 79-year-old suspected mesothelioma patient whose biopsy was done in a minimally-invasive way, under conscious sedation, thanks to the novel use of a standard tool. Although the patient had several of the common signs…

  • |

    New Serum Marker Could Improve Mesothelioma Diagnosis

    Japanese researchers believe they have found a way to diagnose a rare form of mesothelioma earlier using a simple blood test. Diffuse malignant peritoneal mesothelioma (DMPM), which represents about a fourth of all mesothelioma cases, is an aggressive malignancy that spreads across the lining of the abdomen. In most cases, DMPM is lethal within a year. The standard treatment for diffuse malignant peritoneal mesothelioma is cytoreductive surgery to remove as much of the mesothelioma as possible, followed by intraperitoneal chemotherapy to destroy residual cancer cells. In some studies, this approach has resulted in 5-year survival rates of 30 to 60 percent. However, it is most successful when it is performed early, while the primary mesothelioma tumor is more easily removed. Like all forms of…